*Result*: High-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer. oncological outcomes after a median 15-year follow-up

*Publication*:
Freiburg : Universität, 2022
*Physical description scale*:
1 Online-Ressource
*Format*:
*eBook*
*Language*:
*eng*
*Notes*:
Frontiers in oncology. - 11 (2021) , 770959, ISSN: 2234-943X
*DOI*:
10.3389/fonc.2021.770959